GO:1901623 regulation of lymphocyte chemotaxis: Immune Cell Migration Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901623 (regulation of lymphocyte chemotaxis) is a biological process that modulates the frequency, rate or extent of lymphocyte chemotaxis, the directed migration of lymphocytes along chemical gradients.
• Chemokine gradients, circadian clocks, adenosine signaling, RGS proteins and p66Shc are all established regulators of lymphocyte chemotaxis.
• Dysregulation of lymphocyte chemotaxis contributes to impaired antitumor immunity, chronic inflammation and altered lymph node trafficking.
• Key chemokine-receptor axes such as CXCL10-CXCR3 and constitutive/inducible chemokine cooperation control T cell engraftment into solid tumors.
• CRISPR knockout, point mutation, knock-in and overexpression models enable causal dissection of regulators of lymphocyte chemotaxis.
• Studying this process requires integrated methods including live imaging, chemotaxis assays, flow cytometry and transcriptomics.
Description
Regulation of lymphocyte chemotaxis (GO:1901623) is the biological process that modulates the frequency, rate or extent of lymphocyte chemotaxis, the directed movement of lymphocytes along chemical gradients. Lymphocyte chemotaxis is essential for immune surveillance, lymph node trafficking and the positioning of T and B cells within lymphoid and peripheral tissues. Because chemotaxis must be tightly controlled to avoid autoimmunity or immunodeficiency, multiple layers of regulation exist, including chemokine availability, receptor signaling, circadian clocks and intracellular negative regulators. Understanding GO:1901623 therefore matters for immunology, cancer immunotherapy and inflammatory disease research.
regulation of lymphocyte chemotaxis At A Glance
| GO ID | GO:1901623 |
|---|---|
| GO term | regulation of lymphocyte chemotaxis |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that modulates the frequency, rate or extent of lymphocyte chemotaxis. |
| Major function | Controls the speed, frequency and extent of directed lymphocyte migration along chemical gradients. |
| Related processes | Chemokine signaling, circadian regulation, adenosine signaling, RGS-mediated desensitization. |
| Key regulators | CXCL10-CXCR3 axis, RGS proteins, p66Shc, adenosine receptors, circadian clock genes. |
| Disease relevance | Cancer immunotherapy, chronic inflammation, altered lymph node trafficking. |
What Is GO:1901623?
According to the Gene Ontology, GO:1901623 (regulation of lymphocyte chemotaxis) is any process that modulates the frequency, rate or extent of lymphocyte chemotaxis. In other words, it covers all molecular and cellular events that tune how fast, how often or how far a lymphocyte migrates toward a chemoattractant, without itself being the migration event.
Why Is regulation of lymphocyte chemotaxis Important in Cell Biology?
Regulation of lymphocyte chemotaxis is central to adaptive immunity because it determines whether lymphocytes reach the right tissue at the right time. Disruption of this regulation impairs antitumor T cell engraftment and immune attack in solid tumors, alters lymph node trafficking and adaptive immune responses, and contributes to adenosine-driven immunosuppression. Conversely, excessive or misdirected chemotaxis can drive inflammatory pathology. Therefore, GO:1901623 is a high-value target for mechanistic immunology and therapeutic intervention.
• Controls lymph node trafficking and adaptive immune responses via circadian clocks.
• Determines T cell engraftment and immune attack in solid tumors.
• Regulated by adenosine, a major immunosuppressive metabolite.
• Modulated by RGS proteins that desensitize chemokine receptors.
• Negatively regulated by p66Shc in B-cell chemotaxis.
• CXCL10 carboxyterminal truncation attenuates lymphocyte chemotaxis.
• Relevant to gastrointestinal eosinophil biology and inflammation.
• Studied in avian spleen lymphocyte homing during LPS stimulation.
• Provides targets for cancer immunotherapy and anti-inflammatory drugs.
• Requires integrated imaging and chemotaxis assays for functional validation.
What Happens During regulation of lymphocyte chemotaxis?
Chemokine gradient formation and sensing
In simple terms: Cells follow chemical trails, and the body controls how strong those trails are.
Lymphocyte chemotaxis depends on chemokine gradients that are sensed by chemokine receptors. Constitutive and inducible chemokines cooperate to enable T cell engraftment and immune attack in solid tumors. Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding and CXCR3A signaling, thereby reducing lymphocyte chemotaxis. Thus, regulation of lymphocyte chemotaxis begins with modulation of chemokine availability and receptor engagement.
Circadian control of lymph node trafficking
In simple terms: The body clock tells lymphocytes when to move.
Lymphocyte circadian clocks control lymph node trafficking and adaptive immune responses. Disruption of these clocks alters the frequency and extent of lymphocyte chemotaxis, linking GO:1901623 to daily rhythms in immunity.
Adenosine and immunosuppressive regulation
In simple terms: A small molecule called adenosine can put the brakes on lymphocyte movement.
Adenosine regulates lymphocyte function, including chemotaxis, through adenosine receptors. This pathway is a key negative regulator of lymphocyte chemotaxis in inflamed and tumor microenvironments.
RGS proteins and receptor desensitization
In simple terms: RGS proteins act like dimmer switches on chemokine receptors.
RGS proteins regulate chemokine-induced lymphocyte migration by desensitizing G-protein-coupled receptor signaling. This provides a negative feedback mechanism that tunes the rate and extent of lymphocyte chemotaxis.
p66Shc as a negative regulator
In simple terms: p66Shc is a brake on B-cell chemotaxis.
p66Shc negatively regulates chemokine receptor signaling and B-cell chemotaxis. Loss of p66Shc enhances chemotaxis, demonstrating that GO:1901623 includes active inhibitory pathways.
Tissue-specific regulation in spleen and gut
In simple terms: Different organs have their own rules for lymphocyte movement.
Cytological studies show regulation of lymphocyte homing in the chicken spleen during LPS stimulation. Gastrointestinal eosinophils also illustrate tissue-specific regulation of lymphocyte chemotaxis in mucosal immunity.
Key Genes Involved in GO:1901623 regulation of lymphocyte chemotaxis
The following genes and proteins are established regulators or effectors of lymphocyte chemotaxis based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL10 | Chemokine ligand for CXCR3 | Truncation attenuates lymphocyte chemotaxis |
| CXCR3 | Chemokine receptor | Mediates CXCL10-driven chemotaxis |
| CCL21 | Constitutive chemokine | Supports T cell engraftment in tumors |
| CXCL9 | Inducible chemokine | Cooperates with CCL21 for T cell attack |
| RGS1 | Regulator of G-protein signaling | Desensitizes chemokine receptors |
| RGS2 | Regulator of G-protein signaling | Modulates lymphocyte migration |
| RGS3 | Regulator of G-protein signaling | Controls chemokine-induced migration |
| p66Shc | Adaptor protein | Negative regulator of B-cell chemotaxis |
| ADORA2A | Adenosine receptor | Mediates adenosine suppression of lymphocyte function |
| ADORA2B | Adenosine receptor | Contributes to adenosine regulation |
| CLOCK | Circadian clock gene | Controls lymph node trafficking |
| BMAL1 | Circadian clock gene | Regulates adaptive immune responses |
| PER1 | Circadian clock gene | Modulates lymphocyte chemotaxis timing |
| PER2 | Circadian clock gene | Modulates lymphocyte chemotaxis timing |
| CRY1 | Circadian clock gene | Regulates lymph node trafficking |
| CRY2 | Circadian clock gene | Regulates lymph node trafficking |
| CCR7 | Chemokine receptor | Mediates lymph node homing |
How Is regulation of lymphocyte chemotaxis Regulated?
Regulation of lymphocyte chemotaxis is itself regulated at multiple levels. Circadian clocks in lymphocytes control lymph node trafficking and adaptive immune responses. Adenosine signaling through adenosine receptors suppresses lymphocyte function, including chemotaxis. RGS proteins provide negative feedback on chemokine receptor signaling, and p66Shc negatively regulates B-cell chemotaxis. Chemokine availability is also regulated by post-translational modifications such as carboxyterminal truncation of CXCL10. Together, these mechanisms tune the frequency, rate and extent of lymphocyte chemotaxis in health and disease.
regulation of lymphocyte chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CXCL10 | Cancer immunotherapy, angiostasis | Knockout or point-mutation in tumor models |
| p66Shc | B-cell chemotaxis, oxidative stress | Knockout mice or B-cell lines |
| ADORA2A | Inflammation, immunosuppression | Knockout or overexpression in T cells |
| CLOCK | Circadian immunity, lymph node trafficking | Knockout or point-mutation in mice |
| RGS1 | Chemokine receptor desensitization | Knockout or overexpression in lymphocytes |
Cancer immunotherapy
Cooperation between constitutive and inducible chemokines enables T cell engraftment and immune attack in solid tumors. Regulation of lymphocyte chemotaxis is therefore critical for the success of cancer immunotherapy, and CXCL10 truncation attenuates lymphocyte chemotaxis while retaining angiostatic activity. Targeting GO:1901623 may improve T cell infiltration into tumors.
Chronic inflammation and autoimmunity
Adenosine regulation of lymphocyte function is a key immunosuppressive pathway that limits excessive inflammation. Dysregulated chemotaxis can contribute to chronic inflammatory diseases, including gastrointestinal eosinophil-associated conditions. Understanding GO:1901623 may reveal new anti-inflammatory targets.
Lymph node trafficking disorders
Circadian clock disruption alters lymph node trafficking and adaptive immune responses. Impaired lymphocyte homing in the spleen during LPS stimulation further illustrates how regulation of lymphocyte chemotaxis affects immune organ function. These findings link GO:1901623 to immune deficiency and altered vaccine responses.
From regulation of lymphocyte chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate lymphocyte chemotaxis? | CRISPR knockout in primary lymphocytes or cell lines |
| Does a point mutation alter chemokine receptor signaling? | CRISPR point mutation knock-in |
| Does a tag affect protein localization during chemotaxis? | Tagged knock-in |
| Does overexpression enhance or suppress chemotaxis? | CRISPR overexpression |
| Which genes are essential for lymph node trafficking? | In vivo CRISPR library screening |
| How does adenosine regulate chemotaxis? | Knockout of adenosine receptors |
How to Study the regulation of lymphocyte chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live imaging | Real-time lymphocyte migration | Lymph node trafficking |
| Transwell chemotaxis assay | Rate and extent of migration | Chemokine response |
| Microfluidic chemotaxis | Directionality and speed | Gradient sensing |
| Flow cytometry | Chemokine receptor expression | Subset analysis |
| RNA-seq | Transcriptional changes | Pathway discovery |
| CRISPR screening | Gene essentiality for chemotaxis | Target identification |
| Western blot | Protein expression and signaling | RGS and p66Shc studies |
Live imaging of lymphocyte chemotaxis
Live imaging allows direct visualization of lymphocyte migration in lymph nodes and tissues, revealing how circadian clocks and chemokine gradients regulate chemotaxis. This method is essential for studying the frequency and extent of migration in real time.
Chemotaxis assays
Transwell and microfluidic chemotaxis assays measure the rate and extent of lymphocyte migration toward chemokines such as CXCL10 and CCL21. These assays are used to quantify the effects of gene knockouts or point mutations on GO:1901623.
Flow cytometry and sorting
Flow cytometry quantifies lymphocyte subsets and their chemokine receptor expression, enabling correlation with chemotaxis behavior. Sorting allows isolation of specific populations for downstream assays.
Transcriptomics and bioinformatics
RNA-seq and bioinformatics analyses identify genes and pathways that regulate lymphocyte chemotaxis, including circadian and adenosine-related genes. These methods help prioritize candidates for CRISPR validation.
How CRISPR Can Be Used to Study GO:1901623 regulation of lymphocyte chemotaxis
Knockout
CRISPR knockout of candidate genes such as RGS1 or p66Shc can test their role in regulating lymphocyte chemotaxis. Knockout models reveal whether a gene is a positive or negative regulator of migration.
Point Mutation
Point mutations in chemokine receptors or signaling molecules can dissect specific residues required for regulation of lymphocyte chemotaxis. For example, mutations affecting CXCR3A signaling alter chemotaxis.
Knock-in
Knock-in of tagged proteins or reporter genes allows tracking of regulators during chemotaxis in vivo. This is useful for studying circadian clock proteins in lymph node trafficking.
Overexpression
Overexpression of chemokines or receptors can enhance or suppress lymphocyte chemotaxis, providing gain-of-function evidence. This approach is valuable for testing therapeutic candidates.
How EDITGENE Supports regulation of lymphocyte chemotaxis Research
Researchers studying regulation of lymphocyte chemotaxis-related genes often need to determine whether a candidate gene is causally involved in migration, and CRISPR-based models provide the most direct way to establish causality. EDITGENE offers a full suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of lymphocyte chemotaxis research.
Frequently Asked Questions About regulation of lymphocyte chemotaxis
What is GO:1901623?
GO:1901623 is the Gene Ontology term for regulation of lymphocyte chemotaxis, defined as any process that modulates the frequency, rate or extent of lymphocyte chemotaxis.
What genes are involved in regulation of lymphocyte chemotaxis?
Key genes include CXCL10, CXCR3, RGS proteins, p66Shc, adenosine receptors and circadian clock genes.
How is lymphocyte chemotaxis regulated?
It is regulated by chemokine gradients, circadian clocks, adenosine signaling, RGS proteins and p66Shc.
Why is regulation of lymphocyte chemotaxis important in cancer?
It determines T cell engraftment and immune attack in solid tumors, making it critical for immunotherapy.
What is the role of CXCL10 in lymphocyte chemotaxis?
CXCL10 is a chemokine that attracts lymphocytes via CXCR3, and its truncation attenuates chemotaxis.
How do circadian clocks affect lymphocyte chemotaxis?
Lymphocyte circadian clocks control lymph node trafficking and adaptive immune responses.
What is the role of adenosine in lymphocyte chemotaxis?
Adenosine regulates lymphocyte function, including chemotaxis, through adenosine receptors.
How do RGS proteins regulate lymphocyte chemotaxis?
RGS proteins desensitize chemokine receptor signaling, thereby modulating migration.
What is the role of p66Shc in B-cell chemotaxis?
p66Shc negatively regulates chemokine receptor signaling and B-cell chemotaxis.
How can CRISPR be used to study regulation of lymphocyte chemotaxis?
CRISPR knockout, point mutation, knock-in and overexpression models can test causal roles of genes in chemotaxis.
Conclusion
GO:1901623 (regulation of lymphocyte chemotaxis) is a critical biological process that controls immune cell positioning and function. Its dysregulation contributes to cancer, inflammation and immune disorders. CRISPR-based models and integrated methods are essential for dissecting its mechanisms and developing new therapies.
References
- 1. Druzd D et al.. 2017. Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses.. Immunity 46(1):120-132 PMID: 28087238
- 2. Dillemans L et al.. 2024. Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity.. Cell Commun Signal 22(1):94 PMID: 38308278
- 3. Dangaj D et al.. 2019. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.. Cancer Cell 35(6):885-900.e10 PMID: 31185212
- 4. Linden J et al.. 2012. Regulation of lymphocyte function by adenosine.. Arterioscler Thromb Vasc Biol 32(9):2097-103 PMID: 22772752
- 5. Moratz C et al.. 2004. Regulation of chemokine-induced lymphocyte migration by RGS proteins.. Methods Enzymol 389:15-32 PMID: 15313557
- 6. Rothenberg ME et al.. 2001. Gastrointestinal eosinophils.. Immunol Rev 179:139-55 PMID: 11292017
- 7. Zhang Q et al.. 2017. Cytological study on the regulation of lymphocyte homing in the chicken spleen during LPS stimulation.. Oncotarget 8(5):7405-7419 PMID: 28061467
- 8. Patrussi L et al.. 2014. Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc.. Cell Death Dis 5(2):e1068 PMID: 24556683
